12th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production

  • ID: 3382827
  • April 2015
  • Region: Global
  • 468 Pages
  • Bioplan Associates Inc
1 of 4

The 2015 12th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production is the most recent study of biotherapeutic developers and contract manufacturing organizations' current and projected future capacity and production. The report contains the industry's definitive, quantitative analysis and includes 12 years of biopharma trends as well as a review of current opportunities and in-depth coverage by several subject matter experts of critical issues affecting the industry.

The survey includes responses from 237 responsible individuals at biopharmaceutical manufacturers and contract manufacturing organizations from 28 countries. The methodology also includes responses from an additional 164 direct suppliers of raw materials, services and equipment to this industry.

Note: Product cover images may vary from those shown
2 of 4

CHAPTER 0: Demographics

CHAPTER 1: Introduction and Discussion

CHAPTER 3: Emerging Issues in Biopharmaceutical Manufacturing

CHAPTER 4: Capacity Utilization

CHAPTER 5: Current and Future Capacity Constraints

CHAPTER 6: Future Capacity Expansions

CHAPTER 7: Outsourcing Trends in Biopharmaceutical Manufacturing

CHAPTER 8: Disposables and Single-Use Systems in Biopharmaceutical Manufacturing

CHAPTER 9: Downstream Purification

CHAPTER 10: Quality Issues, Batch Failures, and PAT in Biopharmaceutical Manufacturing

CHAPTER 11: Hiring, Employment Growth, and Training in Biopharmaceutical

CHAPTER 12: Fill and Finish

CHAPTER 13: Suppliers to Biopharmaceutical Manufacturing and Life Sciences

Note: Product cover images may vary from those shown
3 of 4

The 12th Annual Report and Survey of Biopharmaceutical Manufacturing provides over 12 years of global trend analysis to help your decision-making. The Biopharmaceutical Report covers many critical areas including: industry growth, downstream processing, single use systems, outsourcing, capacity, fill-finish operations, quality management, hiring and much more! Detailed monograph discussions from industry experts are also included, covering the events that have shaped the past year and evaluations of how they will affect, or create trends that will shape biopharmaceutical manufacturing over the next 5 years. This year's edition also includes for the first time a chapter on Fill-and-Finish operations; over the past few years, advances in technologies, drug delivery, and single-use applications have increasingly made this segment an area of interest for innovation.

Top trends identified include:

- Focus today is on manufacturing and productivity
- Operations budgets are growing, from R&D to new capital equipment
- Single-use systems and disposable devices among the new bio-innovations most in demand
- U.S. and EU are stepping up their Biosimilars pipeline
- Hiring growing rapidly in key areas; 51% of companies unable to hire the right PD staff
- China is now the #1 "potential" outsourcing destination
- Suppliers are increasing their R&D and focus on improved productivity
- Fill-Finish operations are going high-tech and single-use
- Bioprocessing is getting better as failure rates have been almost cut in half over the past 8 years

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown


  • Quick Help: A printed copy of the report will be shipped to you.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.


If you have a more general question about our products please try our



Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer, Inc.